JP2015510758A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015510758A5 JP2015510758A5 JP2014560516A JP2014560516A JP2015510758A5 JP 2015510758 A5 JP2015510758 A5 JP 2015510758A5 JP 2014560516 A JP2014560516 A JP 2014560516A JP 2014560516 A JP2014560516 A JP 2014560516A JP 2015510758 A5 JP2015510758 A5 JP 2015510758A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- cells
- apoptosis
- cell population
- inducing ligand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cells Anatomy 0.000 claims 24
- 210000000130 stem cell Anatomy 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 8
- 206010059512 Apoptosis Diseases 0.000 claims 7
- 230000006907 apoptotic process Effects 0.000 claims 7
- 230000027455 binding Effects 0.000 claims 7
- 230000001939 inductive effect Effects 0.000 claims 7
- 239000003446 ligand Substances 0.000 claims 7
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 6
- 108010001801 Tumor Necrosis Factor-alpha Proteins 0.000 claims 6
- 230000001640 apoptogenic Effects 0.000 claims 5
- 230000011664 signaling Effects 0.000 claims 5
- 206010018651 Graft versus host disease Diseases 0.000 claims 4
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 4
- 238000000338 in vitro Methods 0.000 claims 4
- 102000015212 Fas Ligand Protein Human genes 0.000 claims 3
- 108010039471 Fas Ligand Protein Proteins 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 210000003958 Hematopoietic Stem Cells Anatomy 0.000 claims 2
- 239000000560 biocompatible material Substances 0.000 claims 2
- 210000002865 immune cell Anatomy 0.000 claims 2
- 230000003211 malignant Effects 0.000 claims 2
- 238000002054 transplantation Methods 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 239000004743 Polypropylene Substances 0.000 claims 1
- 239000004793 Polystyrene Substances 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 239000011324 bead Substances 0.000 claims 1
- 230000030833 cell death Effects 0.000 claims 1
- -1 polypropylene Polymers 0.000 claims 1
- 229920001155 polypropylene Polymers 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 claims 1
- 229920002223 polystyrene Polymers 0.000 claims 1
- 229920000915 polyvinyl chloride Polymers 0.000 claims 1
- 239000004800 polyvinyl chloride Substances 0.000 claims 1
Claims (15)
- 生体適合材料からなる容器と、表面に固定化された生物学的に活性なアポトーシス誘導リガンドとを含み、細胞選択に適した装置。
- 前記表面が前記容器の内表面、または前記表面が前記容器内に存在するビーズの表面である、請求項1に記載の装置。
- 前記生体適合材料が、ポリプロピレン、ポリスチレン、シリコーン、ポリ塩化ビニルまたはその組合せを含む群から選択される、請求項1に記載の装置。
- 前記固定化されたアポトーシス誘導リガンドが、腫瘍壊死因子α(TNF−α)、Fasリガンド(FasL)、Trail、Tweakまたはその任意の組合せを含む群から選択される、請求項1に記載の装置。
- 細胞集団からアポトーシスシグナル伝達抵抗性細胞を選択するin vitroの方法であって、前記細胞集団がアポトーシスシグナル伝達抵抗性細胞とアポトーシスシグナル伝達感受性細胞とを含み、
(a)細胞集団を含む試料を請求項1に記載の装置内に導入する段階と、
(b)前記装置内で前記細胞をインキュベートする段階と
からなることによって、
細胞集団からアポトーシスシグナル伝達抵抗性細胞を選択する
方法。 - 前記アポトーシスシグナル伝達抵抗性細胞が、幹細胞、活性化誘導細胞死(AICD)に非感受性の免疫細胞、前駆細胞またはその任意の組合せを含む、請求項5に記載の方法。
- (a)請求項1に記載の細胞選択装置と、
(b)前記装置内のアポトーシス誘導リガンドの完全性および活性を維持する溶液と
を含む、細胞選択キット。 - 追加のアポトーシス誘導リガンドをさらに含む、請求項7に記載のキット。
- 前記容器内の前記アポトーシス誘導リガンドが、腫瘍壊死因子α(TNF−α)、Fasリガンド(FasL)、Trail、Tweakまたはその任意の組合せである、請求項8に記載のキット。
- 造血幹/前駆細胞(HSPC)移植の臨床転帰を改善するin vitroの方法であって、
(a)幹/前駆細胞を含む細胞集団を含む試料を準備する段階と、
(b)前記細胞集団とFasリガンド(FasL)とを1〜24時間接触させる段階と、または前記細胞集団と腫瘍壊死因子α(TNF−α)とを24〜48時間接触させる段階と、
(c)段階(b)の細胞を回収する段階と、
(d)段階(c)の細胞を移植する段階と
を含むことによって、
造血幹/前駆細胞(HSPC)移植の臨床転帰を改善する
方法。 - 請求項1に記載の装置を用いて段階(b)を実施する、請求項10に記載の方法。
- 前駆細胞移植片を含む組成物中の悪性細胞を排除するin vitroの方法であって、
(a)前駆細胞移植片を含む組成物を準備する段階と、
(b)前記組成物とアポトーシス誘導リガンドとを約24時間接触させる段階と
を含むことによって、
前駆細胞移植片を含む組成物中の悪性細胞を排除する
方法。 - 請求項1に記載の装置を用いて段階(b)を実施する、請求項12に記載の方法。
- 移植片対腫瘍(GvT)活性を保持しながら移植片対宿主病(GvHD)を予防するin vitroの方法であって、
(a)HSPCと免疫細胞とを含む細胞集団を含む試料を準備する段階と、
(b)前記細胞集団とアポトーシス誘導リガンドとを2〜16時間接触させる段階と、
(c)段階(b)の細胞を回収する段階と、
(d)段階(c)の細胞を移植する段階と
を含むことによって、
移植片対腫瘍(GvT)活性を保持しながら移植片対宿主病(GvHD)を予防する
方法。 - 請求項1に記載の装置を用いて段階(b)を実施する、請求項14に記載の方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261607033P | 2012-03-06 | 2012-03-06 | |
PCT/IL2013/000026 WO2013132477A1 (en) | 2012-03-06 | 2013-03-05 | Devices and methods for selecting apoptosis-signaling resistant cells, and uses thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2015510758A JP2015510758A (ja) | 2015-04-13 |
JP2015510758A5 true JP2015510758A5 (ja) | 2016-04-21 |
JP6429191B2 JP6429191B2 (ja) | 2018-11-28 |
Family
ID=49116028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014560516A Active JP6429191B2 (ja) | 2012-03-06 | 2013-03-05 | アポトーシスシグナル伝達抵抗性細胞を選択する装置および方法ならびにその使用 |
Country Status (11)
Country | Link |
---|---|
US (2) | US9783778B2 (ja) |
EP (2) | EP3486315A1 (ja) |
JP (1) | JP6429191B2 (ja) |
KR (1) | KR101912982B1 (ja) |
CN (2) | CN109116033A (ja) |
AU (1) | AU2013229008B2 (ja) |
CA (1) | CA2866358C (ja) |
DK (1) | DK2823040T3 (ja) |
IL (1) | IL234459B (ja) |
RU (1) | RU2630301C2 (ja) |
WO (1) | WO2013132477A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016538253A (ja) * | 2013-10-09 | 2016-12-08 | セレクト バイオセラピューティクス リミテッド | デスリガンドへの移植前曝露による造血前駆細胞の活性化 |
WO2016193986A2 (en) | 2015-06-05 | 2016-12-08 | Cellect Biotherapeutics Ltd. | Selective surfaces for, and methods of, selecting a population of stem and progenitor cells, and uses thereof |
CA3110018A1 (en) * | 2018-08-22 | 2020-02-27 | Cellect Biotherapeutics Ltd. | Modulation of apoptosis susceptible cells |
US20220002363A1 (en) * | 2020-07-03 | 2022-01-06 | United States Government As Represented By The Department Of Veterans Affairs | Compositions and methods for treating pulmonary disease |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
JPS61235752A (ja) | 1985-04-11 | 1986-10-21 | Asahi Optical Co Ltd | 細胞分離材、分離器および分離方法 |
IT8523298V0 (it) * | 1985-10-02 | 1985-10-02 | Pierrel Hospital Spa | Catetere venoso centrale. |
US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
US4979959A (en) | 1986-10-17 | 1990-12-25 | Bio-Metric Systems, Inc. | Biocompatible coating for solid surfaces |
US4885234A (en) | 1988-09-29 | 1989-12-05 | Eastman Kodak Company | Photographic materials containing stable cyan coupler formulations |
US5998024A (en) | 1995-02-02 | 1999-12-07 | Rainer H. Frey | Biocompatible material and method of manufacture and use thereof |
CA2290443A1 (en) | 1997-05-14 | 1998-11-19 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Peptide parathyroid hormone analogs |
US6040182A (en) | 1997-11-12 | 2000-03-21 | Becton Dickinson And Company | Method and materials for efficiency protein immobilization on tissue culture treated assay plates |
GB9724270D0 (en) | 1997-11-17 | 1998-01-14 | Babraham The Inst | Methods and means for mutagenesis of dna |
US6526984B1 (en) | 1998-04-22 | 2003-03-04 | St. Jude Medical Ab | Biocompatible material for implants |
US20010049115A1 (en) * | 2000-01-17 | 2001-12-06 | Collins John Kevin | Vitro model for gastrointestinal inflammation |
US20090130718A1 (en) | 1999-02-04 | 2009-05-21 | Diversa Corporation | Gene site saturation mutagenesis |
US20030119185A1 (en) * | 2000-02-24 | 2003-06-26 | Xcyte Therapies, Inc. | Activation and expansion of cells |
WO2003002761A1 (en) | 2001-06-29 | 2003-01-09 | Novozymes A/S | Method of multimerization and site-directed mutagenesis |
US20030044389A1 (en) | 2001-07-02 | 2003-03-06 | Brown Patrick O. | Microarrays for cell phenotyping and manipulation |
EP1281767A3 (en) | 2001-07-31 | 2003-05-28 | Aladar A. Szalay | Light emitting microorganisms and cells for diagnosis and therapy of tumors |
DE10144252A1 (de) * | 2001-08-31 | 2003-03-27 | Fraunhofer Ges Forschung | Nanopartikel mit daran immobilisiertem biologisch aktivem TNF |
JP2005529187A (ja) * | 2002-06-13 | 2005-09-29 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 同種抗原の特定方法、ならびに癌治療および移植へのその使用 |
US20040115216A1 (en) * | 2002-07-12 | 2004-06-17 | The Johns Hopkins University | Reagents and methods for engaging unique clonotypic lymphocyte receptors |
US20060009623A1 (en) | 2004-07-06 | 2006-01-12 | National University Of Singapore | C-terminal attachment of ligands to proteins for immobilization onto a support |
US20080241109A1 (en) * | 2004-10-01 | 2008-10-02 | Marc Dupuis | Method for Ex-Vivo Purging in Autologous Transplantation |
ZA200704252B (en) * | 2004-10-25 | 2009-09-30 | Cellerant Therapeutics Inc | Methods of expanding myeloid cell populations and uses thereof |
DE602005008265D1 (de) * | 2005-12-23 | 2008-08-28 | Biedermann Motech Gmbh | Flexible Stabilisierungsvorrichtung zur dynamischen Stabilisierung von Knochen oder Wirbeln |
CN101517070A (zh) * | 2006-05-31 | 2009-08-26 | Styx有限责任公司 | 选择干细胞的方法及其用途 |
AU2007266565A1 (en) | 2006-05-31 | 2007-12-06 | Styx Llc | Methods of selecting stem cells and uses thereof |
JP5700934B2 (ja) * | 2007-03-16 | 2015-04-15 | セルスティス リミテッド | 細胞性免疫反応アッセイおよびそのためのキット |
KR100920729B1 (ko) | 2007-10-01 | 2009-10-07 | 한국생명공학연구원 | 펩타이드 혼성체를 사용한 배향성이 조절된 항체단분자막의 제조방법 |
EP2282746B8 (en) | 2008-03-27 | 2015-12-09 | Caladrius Biosciences, Inc. | Compositions and methods using stem cells in cutaneous wound healing |
JP2011522515A (ja) * | 2008-04-10 | 2011-08-04 | マサチューセッツ インスティテュート オブ テクノロジー | 癌幹細胞を標的とする薬剤を同定する方法およびその使用 |
WO2009152487A2 (en) | 2008-06-13 | 2009-12-17 | Smith & Nephew, Inc. | Fixation devices for tissue repair |
BRPI0921726B8 (pt) * | 2008-10-31 | 2021-07-27 | Synthes Gmbh | método para preparar uma composição de implante para promover o crescimento ósseo em um mamífero |
GB0823553D0 (en) | 2008-12-24 | 2009-01-28 | Immunosolv Ltd | Cell separation technique |
JP5327457B2 (ja) | 2009-03-27 | 2013-10-30 | セイコーエプソン株式会社 | がん細胞分離装置およびその製造方法 |
JP2010227313A (ja) | 2009-03-27 | 2010-10-14 | Seiko Epson Corp | がん細胞除去システムおよびがん細胞除去装置 |
US9624469B2 (en) * | 2010-07-22 | 2017-04-18 | Cellect Biotherapeutics Ltd. | Regulatory immune cells with enhanced targeted cell death effect |
-
2013
- 2013-03-05 KR KR1020147027817A patent/KR101912982B1/ko active IP Right Grant
- 2013-03-05 JP JP2014560516A patent/JP6429191B2/ja active Active
- 2013-03-05 CN CN201810972287.2A patent/CN109116033A/zh active Pending
- 2013-03-05 WO PCT/IL2013/000026 patent/WO2013132477A1/en active Application Filing
- 2013-03-05 EP EP18181773.5A patent/EP3486315A1/en not_active Withdrawn
- 2013-03-05 CA CA2866358A patent/CA2866358C/en active Active
- 2013-03-05 AU AU2013229008A patent/AU2013229008B2/en not_active Ceased
- 2013-03-05 DK DK13758162.5T patent/DK2823040T3/en active
- 2013-03-05 US US14/383,288 patent/US9783778B2/en active Active
- 2013-03-05 RU RU2014138001A patent/RU2630301C2/ru active
- 2013-03-05 CN CN201380021092.5A patent/CN104245924B/zh active Active
- 2013-03-05 EP EP13758162.5A patent/EP2823040B1/en active Active
-
2014
- 2014-09-04 IL IL234459A patent/IL234459B/en active IP Right Grant
-
2017
- 2017-09-07 US US15/697,928 patent/US20180208888A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9267101B2 (en) | Cell culture insert | |
Flores-Guzmán et al. | Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine | |
Dalerba et al. | Cancer stem cells: models and concepts | |
Choi et al. | Engineering the hematopoietic stem cell niche: Frontiers in biomaterial science | |
Feng et al. | Expansion of engrafting human hematopoietic stem/progenitor cells in three‐dimensional scaffolds with surface‐immobilized fibronectin | |
Poulos et al. | Activation of the vascular niche supports leukemic progression and resistance to chemotherapy | |
Seyfried et al. | Macrophages orchestrate hematopoietic programs and regulate HSC function during inflammatory stress | |
JP2012521215A5 (ja) | ||
Nakamura | Recent progress in organoid culture to model intestinal epithelial barrier functions | |
JP2015510758A5 (ja) | ||
Magnusson et al. | Expansion on stromal cells preserves the undifferentiated state of human hematopoietic stem cells despite compromised reconstitution ability | |
JP2015061520A5 (ja) | ||
Baek et al. | Ex vivo expansion of natural killer cells using cryopreserved irradiated feeder cells | |
JP2017536826A5 (ja) | ||
Li et al. | Characteristics of CD8+ and CD4+ tissue‐resident memory lymphocytes in the gastrointestinal tract | |
Blau | Bone marrow stromal cells in the pathogenesis of acute myeloid leukemia | |
Haniuda et al. | In vitro-induced germinal center b cell culture system | |
Mayer et al. | Isolation, maintenance and expansion of adult hematopoietic stem/progenitor cells and leukemic stem cells | |
Oh et al. | Normal and leukemic stem cell niche interactions | |
JP2018528782A5 (ja) | ||
RU2014138001A (ru) | Устройства и способы для отбора клеток, устойчивых к апоптотическим сигналам, и области их применения | |
Zhang et al. | Current trends and research topics regarding intestinal organoids: an overview based on bibliometrics | |
Son et al. | Enhanced maturation and function of dendritic cells using hydrogel coated plate and antigen electroporation | |
Saxena et al. | Epigenetic signatures and plasticity of intestinal and other stem cells | |
JP5777299B2 (ja) | 組織幹細胞の増殖方法、およびそれより得られる組織幹細胞 |